Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 164

1.

Altered arachidonic acid-derived inflammatory eicosanoids brain levels in a rodent model of anorexia nervosa.

Collu R, Post JM, Scherma M, Giunti E, Fratta W, Lutz B, Fadda P, Bindila L.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Nov 25:158578. doi: 10.1016/j.bbalip.2019.158578. [Epub ahead of print]

PMID:
31778792
2.

Gene knockout animal models of depression, anxiety and obsessive compulsive disorders.

Scherma M, Giunti E, Fratta W, Fadda P.

Psychiatr Genet. 2019 Oct;29(5):191-199. doi: 10.1097/YPG.0000000000000238.

PMID:
31464999
3.

Impaired brain endocannabinoid tone in the activity-based model of anorexia nervosa.

Collu R, Scherma M, Piscitelli F, Giunti E, Satta V, Castelli MP, Verde R, Fratta W, Bisogno T, Fadda P.

Int J Eat Disord. 2019 Nov;52(11):1251-1262. doi: 10.1002/eat.23157. Epub 2019 Aug 27.

PMID:
31456239
4.

Sex and Feeding Status Differently Affect Natural Reward Seeking Behavior in Olfactory Bulbectomized Rats.

Ruda-Kucerova J, Zanda MT, Amchova P, Fratta W, Fattore L.

Front Behav Neurosci. 2018 Oct 30;12:255. doi: 10.3389/fnbeh.2018.00255. eCollection 2018.

5.

New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders.

Scherma M, Masia P, Deidda M, Fratta W, Tanda G, Fadda P.

Medicines (Basel). 2018 Oct 2;5(4). pii: E107. doi: 10.3390/medicines5040107. Review.

6.

Brain activity of anandamide: a rewarding bliss?

Scherma M, Masia P, Satta V, Fratta W, Fadda P, Tanda G.

Acta Pharmacol Sin. 2019 Mar;40(3):309-323. doi: 10.1038/s41401-018-0075-x. Epub 2018 Jul 26. Review.

PMID:
30050084
7.

Sex-specific differences in cannabinoid-induced extracellular-signal-regulated kinase phosphorylation in the cingulate cortex, prefrontal cortex, and nucleus accumbens of Lister Hooded rats.

Rosas M, Porru S, Giugliano V, Antinori S, Scheggi S, Fadda P, Fratta W, Acquas E, Fattore L.

Behav Pharmacol. 2018 Sep;29(6):473-481. doi: 10.1097/FBP.0000000000000395.

PMID:
29595540
8.

Cannabinoid Modulation of Eukaryotic Initiation Factors (eIF2α and eIF2B1) and Behavioral Cross-Sensitization to Cocaine in Adolescent Rats.

Melas PA, Qvist JS, Deidda M, Upreti C, Wei YB, Sanna F, Fratta W, Scherma M, Fadda P, Kandel DB, Kandel ER.

Cell Rep. 2018 Mar 13;22(11):2909-2923. doi: 10.1016/j.celrep.2018.02.065.

9.

Limited Access to a High Fat Diet Alters Endocannabinoid Tone in Female Rats.

Satta V, Scherma M, Piscitelli F, Usai P, Castelli MP, Bisogno T, Fratta W, Fadda P.

Front Neurosci. 2018 Feb 2;12:40. doi: 10.3389/fnins.2018.00040. eCollection 2018.

10.

Methoxetamine affects brain processing involved in emotional response in rats.

Zanda MT, Fadda P, Antinori S, Di Chio M, Fratta W, Chiamulera C, Fattore L.

Br J Pharmacol. 2017 Oct;174(19):3333-3345. doi: 10.1111/bph.13952. Epub 2017 Aug 19.

11.

Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.

Scherma M, Satta V, Collu R, Boi MF, Usai P, Fratta W, Fadda P.

Br J Pharmacol. 2017 Aug;174(16):2682-2695. doi: 10.1111/bph.13892. Epub 2017 Jul 11.

12.

Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study.

Primavera D, Manchia M, Deriu L, Tusconi M, Collu R, Scherma M, Fadda P, Fratta W, Carpiniello B.

BMJ Open. 2017 May 25;7(5):e014938. doi: 10.1136/bmjopen-2016-014938.

13.

Levodopa prevents the reinstatement of cocaine self-administration in rats via potentiation of dopamine release in the medial prefrontal cortex.

Antinori S, Fattore L, Saba P, Fratta W, Gessa GL, Devoto P.

Addict Biol. 2018 Mar;23(2):556-568. doi: 10.1111/adb.12509. Epub 2017 Apr 21.

PMID:
28429835
14.

The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function.

Struik D, Fadda P, Zara T, Zamberletti E, Rubino T, Parolaro D, Fratta W, Fattore L.

Pharmacol Res. 2017 Jan;115:209-217. doi: 10.1016/j.phrs.2016.11.031. Epub 2016 Nov 24.

PMID:
27890818
15.

Emotional profile of female rats showing binge eating behavior.

Satta V, Scherma M, Giunti E, Collu R, Fattore L, Fratta W, Fadda P.

Physiol Behav. 2016 Sep 1;163:136-143. doi: 10.1016/j.physbeh.2016.05.013. Epub 2016 May 11. No abstract available.

PMID:
27180132
16.

Methoxetamine, a novel psychoactive substance with serious adverse pharmacological effects: a review of case reports and preclinical findings.

Zanda MT, Fadda P, Chiamulera C, Fratta W, Fattore L.

Behav Pharmacol. 2016 Sep;27(6):489-96. doi: 10.1097/FBP.0000000000000241. Review.

PMID:
27128862
17.

Interactions between the endocannabinoid and nicotinic cholinergic systems: preclinical evidence and therapeutic perspectives.

Scherma M, Muntoni AL, Melis M, Fattore L, Fadda P, Fratta W, Pistis M.

Psychopharmacology (Berl). 2016 May;233(10):1765-77. doi: 10.1007/s00213-015-4196-3. Epub 2016 Jan 4. Review.

PMID:
26728894
18.

Adolescent Δ(9)-Tetrahydrocannabinol Exposure Alters WIN55,212-2 Self-Administration in Adult Rats.

Scherma M, Dessì C, Muntoni AL, Lecca S, Satta V, Luchicchi A, Pistis M, Panlilio LV, Fattore L, Goldberg SR, Fratta W, Fadda P.

Neuropsychopharmacology. 2016 Apr;41(5):1416-26. doi: 10.1038/npp.2015.295. Epub 2015 Sep 21.

19.

Analysis of opioid-seeking reinstatement in the rat.

Fattore L, Fadda P, Zanda MT, Fratta W.

Methods Mol Biol. 2015;1230:295-307. doi: 10.1007/978-1-4939-1708-2_25.

PMID:
25293336
20.

Role of opioid receptors in the reinstatement of opioid-seeking behavior: an overview.

Fattore L, Fadda P, Antinori S, Fratta W.

Methods Mol Biol. 2015;1230:281-93. doi: 10.1007/978-1-4939-1708-2_24. Review.

PMID:
25293335
21.

Elevated dopamine in the medial prefrontal cortex suppresses cocaine seeking via D1 receptor overstimulation.

Devoto P, Fattore L, Antinori S, Saba P, Frau R, Fratta W, Gessa GL.

Addict Biol. 2016 Jan;21(1):61-71. doi: 10.1111/adb.12178. Epub 2014 Aug 19.

PMID:
25135633
22.

Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat.

Serra V, Fattore L, Scherma M, Collu R, Spano MS, Fratta W, Fadda P.

Psychopharmacology (Berl). 2015 Jan;232(1):91-100. doi: 10.1007/s00213-014-3641-z. Epub 2014 Jun 13.

PMID:
24923984
23.

Sex differences in addictive disorders.

Fattore L, Melis M, Fadda P, Fratta W.

Front Neuroendocrinol. 2014 Aug;35(3):272-84. doi: 10.1016/j.yfrne.2014.04.003. Epub 2014 Apr 21. Review.

PMID:
24769267
24.

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms.

Amchova P, Kucerova J, Giugliano V, Babinska Z, Zanda MT, Scherma M, Dusek L, Fadda P, Micale V, Sulcova A, Fratta W, Fattore L.

Front Pharmacol. 2014 Mar 20;5:44. doi: 10.3389/fphar.2014.00044. eCollection 2014.

25.

Nicotine consumption is regulated by a human polymorphism in dopamine neurons.

Morel C, Fattore L, Pons S, Hay YA, Marti F, Lambolez B, De Biasi M, Lathrop M, Fratta W, Maskos U, Faure P.

Mol Psychiatry. 2014 Aug;19(8):930-6. doi: 10.1038/mp.2013.158. Epub 2013 Dec 3.

PMID:
24296975
26.

Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid.

Justinova Z, Mascia P, Wu HQ, Secci ME, Redhi GH, Panlilio LV, Scherma M, Barnes C, Parashos A, Zara T, Fratta W, Solinas M, Pistis M, Bergman J, Kangas BD, Ferré S, Tanda G, Schwarcz R, Goldberg SR.

Nat Neurosci. 2013 Nov;16(11):1652-61. doi: 10.1038/nn.3540. Epub 2013 Oct 13.

27.

Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones.

Castelli MP, Fadda P, Casu A, Spano MS, Casti A, Fratta W, Fattore L.

Curr Pharm Des. 2014;20(13):2100-13. Epub 2013 Jul 9.

PMID:
23829370
28.

The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence.

Scherma M, Fattore L, Castelli MP, Fratta W, Fadda P.

Curr Pharm Des. 2014;20(13):2089-99. Epub 2013 Jul 9. Review.

PMID:
23829365
29.

PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors.

Melis M, Scheggi S, Carta G, Madeddu C, Lecca S, Luchicchi A, Cadeddu F, Frau R, Fattore L, Fadda P, Ennas MG, Castelli MP, Fratta W, Schilstrom B, Banni S, De Montis MG, Pistis M.

J Neurosci. 2013 Apr 3;33(14):6203-11. doi: 10.1523/JNEUROSCI.4647-12.2013.

30.

Molecular mechanisms of cannabinoid addiction.

Fratta W, Fattore L.

Curr Opin Neurobiol. 2013 Aug;23(4):487-92. doi: 10.1016/j.conb.2013.02.002. Epub 2013 Mar 13. Review.

PMID:
23490548
31.

AM404 attenuates reinstatement of nicotine seeking induced by nicotine-associated cues and nicotine priming but does not affect nicotine- and food-taking.

Gamaleddin I, Guranda M, Scherma M, Fratta W, Makriyannis A, Vadivel SK, Goldberg SR, Le Foll B.

J Psychopharmacol. 2013 Jun;27(6):564-71. doi: 10.1177/0269881113477710. Epub 2013 Feb 20.

32.

Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.

Scherma M, Fattore L, Satta V, Businco F, Pigliacampo B, Goldberg SR, Dessi C, Fratta W, Fadda P.

Br J Pharmacol. 2013 Jun;169(4):820-33. doi: 10.1111/bph.12014.

33.

Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.

Spano MS, Fattore L, Cadeddu F, Fratta W, Fadda P.

Psychopharmacology (Berl). 2013 Feb;225(3):531-42. doi: 10.1007/s00213-012-2839-1. Epub 2012 Aug 19.

PMID:
22903392
34.

Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation.

Zamberletti E, Piscitelli F, Cadeddu F, Rubino T, Fratta W, Fadda P, Di Marzo V, Parolaro D.

Br J Pharmacol. 2012 Dec;167(8):1652-64. doi: 10.1111/j.1476-5381.2012.02095.x.

35.

Beyond THC: The New Generation of Cannabinoid Designer Drugs.

Fattore L, Fratta W.

Front Behav Neurosci. 2011 Sep 21;5:60. doi: 10.3389/fnbeh.2011.00060. eCollection 2011.

36.

The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats.

Scherma M, Justinová Z, Zanettini C, Panlilio LV, Mascia P, Fadda P, Fratta W, Makriyannis A, Vadivel SK, Gamaleddin I, Le Foll B, Goldberg SR.

Br J Pharmacol. 2012 Apr;165(8):2539-48. doi: 10.1111/j.1476-5381.2011.01467.x.

37.

Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.

Fattore L, Spano M, Melis V, Fadda P, Fratta W.

Br J Pharmacol. 2011 Aug;163(7):1550-62. doi: 10.1111/j.1476-5381.2011.01459.x.

38.

Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors.

Mascia P, Pistis M, Justinova Z, Panlilio LV, Luchicchi A, Lecca S, Scherma M, Fratta W, Fadda P, Barnes C, Redhi GH, Yasar S, Le Foll B, Tanda G, Piomelli D, Goldberg SR.

Biol Psychiatry. 2011 Apr 1;69(7):633-41. doi: 10.1016/j.biopsych.2010.07.009.

39.

Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.

Fattore L, Spano MS, Altea S, Fadda P, Fratta W.

Br J Pharmacol. 2010 Jun;160(3):724-35. doi: 10.1111/j.1476-5381.2010.00734.x.

40.

How important are sex differences in cannabinoid action?

Fattore L, Fratta W.

Br J Pharmacol. 2010 Jun;160(3):544-8. doi: 10.1111/j.1476-5381.2010.00776.x. Review.

41.

Peroxisome proliferator-activated receptors-alpha modulate dopamine cell activity through nicotinic receptors.

Melis M, Carta S, Fattore L, Tolu S, Yasar S, Goldberg SR, Fratta W, Maskos U, Pistis M.

Biol Psychiatry. 2010 Aug 1;68(3):256-64. doi: 10.1016/j.biopsych.2010.04.016. Epub 2010 Jun 8.

42.

The endocannabinoid system and nondrug rewarding behaviours.

Fattore L, Melis M, Fadda P, Pistis M, Fratta W.

Exp Neurol. 2010 Jul;224(1):23-36. doi: 10.1016/j.expneurol.2010.03.020. Epub 2010 Mar 29. Review.

PMID:
20353776
43.
44.

Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult rats.

Spano MS, Fadda P, Frau R, Fattore L, Fratta W.

Eur Neuropsychopharmacol. 2010 Jan;20(1):25-36. doi: 10.1016/j.euroneuro.2009.09.004.

PMID:
19854030
45.

Sex differences in the self-administration of cannabinoids and other drugs of abuse.

Fattore L, Fadda P, Fratta W.

Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S227-36. doi: 10.1016/j.psyneuen.2009.08.008.

PMID:
19744795
46.

Baclofen prevents drug-induced reinstatement of extinguished nicotine-seeking behaviour and nicotine place preference in rodents.

Fattore L, Spano MS, Cossu G, Scherma M, Fratta W, Fadda P.

Eur Neuropsychopharmacol. 2009 Jul;19(7):487-98. doi: 10.1016/j.euroneuro.2009.01.007. Epub 2009 Feb 28.

PMID:
19250803
47.

The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.

Scherma M, Fadda P, Le Foll B, Forget B, Fratta W, Goldberg SR, Tanda G.

CNS Neurol Disord Drug Targets. 2008 Nov;7(5):468-81. Review.

48.

Sex differences in drug addiction: a review of animal and human studies.

Fattore L, Altea S, Fratta W.

Womens Health (Lond). 2008 Jan;4:51-65. doi: 10.2217/17455057.4.1.51. Review.

PMID:
19072451
49.

Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration.

Pons S, Fattore L, Cossu G, Tolu S, Porcu E, McIntosh JM, Changeux JP, Maskos U, Fratta W.

J Neurosci. 2008 Nov 19;28(47):12318-27. doi: 10.1523/JNEUROSCI.3918-08.2008.

50.

Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.

Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, Justinová Z, Mikics E, Haller J, Medalie J, Stroik J, Barnes C, Yasar S, Tanda G, Piomelli D, Fratta W, Goldberg SR.

J Pharmacol Exp Ther. 2008 Nov;327(2):482-90. doi: 10.1124/jpet.108.142224. Epub 2008 Aug 25. Erratum in: J Pharmacol Exp Ther. 2011 Jun;337(3):887.

Supplemental Content

Loading ...
Support Center